The Promise of Synovial Joint-on-a-Chip in Rheumatoid Arthritis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Sep 26

PMID 39324139

Authors

Xin Zhang

Rui Su

Hui Wang

Ruihe Wu

Yuxin Fan

Zexuan Bin

Chong Gao

Caihong Wang

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) affects millions of people worldwide, but there are limited drugs available to treat it, so acquiring a more comprehensive comprehension of the underlying reasons and mechanisms behind inflammation is crucial, as well as developing novel therapeutic approaches to manage it and mitigate or forestall associated harm. It is evident that current models cannot faithfully replicate all aspects of joint diseases, which makes them ineffective as tools for disease research and drug testing. Organ-on-a-chip (OoC) technology is an innovative platform that can mimic the microenvironment and physiological state of living tissues more realistically than traditional methods by simulating the spatial arrangement of cells and interorgan communication. This technology allows for the precise control of fluid flow, nutrient exchange, and the transmission of physicochemical signals, such as bioelectrical, mechanical stimulation and shear force. In addition, the integration of cutting-edge technologies like sensors, 3D printing, and artificial intelligence enhances the capabilities of these models. Here, we delve into OoC models with a particular focus on Synovial Joints-on-a-Chip, where we outline their structure and function, highlighting the potential of the model to advance our understanding of RA. We integrate the actual evidence regarding various OoC models and their possible integration for multisystem disease study in RA research for the first time and introduce the prospects and opportunities of the chip in RA etiology and pathological mechanism research, drug research, disease prevention and human precision medicine. Although many challenges remain, OoC holds great promise as an model that approaches physiology and dynamics.

References

Maoz B, Herland A, Henry O, Leineweber W, Yadid M, Doyle J . Organs-on-Chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities. Lab Chip. 2017; 17(13):2294-2302. DOI: 10.1039/c7lc00412e. View

Cecen B, Karavasili C, Nazir M, Bhusal A, Dogan E, Shahriyari F . Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives. Pharmaceutics. 2021; 13(10). PMC: 8540732. DOI: 10.3390/pharmaceutics13101657. View

Pocock K, Delon L, Bala V, Rao S, Priest C, Prestidge C . Intestine-on-a-Chip Microfluidic Model for Efficient in Vitro Screening of Oral Chemotherapeutic Uptake. ACS Biomater Sci Eng. 2021; 3(6):951-959. DOI: 10.1021/acsbiomaterials.7b00023. View

Alberti M, Dancik Y, Sriram G, Wu B, Teo Y, Feng Z . Multi-chamber microfluidic platform for high-precision skin permeation testing. Lab Chip. 2017; 17(9):1625-1634. DOI: 10.1039/c6lc01574c. View

Shin W, Kim H . Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci U S A. 2018; 115(45):E10539-E10547. PMC: 6233106. DOI: 10.1073/pnas.1810819115. View

Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

Lee J, Kim S . Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity. Curr Drug Metab. 2018; 19(7):577-583. DOI: 10.2174/1389200219666180309101844. View

Corgier B, Marquette C, Blum L . Direct electrochemical addressing of immunoglobulins: immuno-chip on screen-printed microarray. Biosens Bioelectron. 2006; 22(7):1522-6. DOI: 10.1016/j.bios.2006.05.016. View

Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M . Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater. 2020; 116:67-83. DOI: 10.1016/j.actbio.2020.08.041. View

10.

Lave T, Parrott N, Grimm H, Fleury A, Reddy M . Challenges and opportunities with modelling and simulation in drug discovery and drug development. Xenobiotica. 2007; 37(10-11):1295-310. DOI: 10.1080/00498250701534885. View

11.

Sontheimer-Phelps A, Hassell B, Ingber D . Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019; 19(2):65-81. DOI: 10.1038/s41568-018-0104-6. View

12.

Griffith L, Swartz M . Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006; 7(3):211-24. DOI: 10.1038/nrm1858. View

13.

de Gracia Villa M, Jimenez-Jorquera C, Haro I, Gomara M, Sanmarti R, Fernandez-Sanchez C . Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis. Biosens Bioelectron. 2011; 27(1):113-8. DOI: 10.1016/j.bios.2011.06.026. View

14.

Makarczyk M, Hines S, Yagi H, Li Z, Aguglia A, Zbikowski J . Using Microphysiological System for the Development of Treatments for Joint Inflammation and Associated Cartilage Loss-A Pilot Study. Biomolecules. 2023; 13(2). PMC: 9952916. DOI: 10.3390/biom13020384. View

15.

Lin Z, Li Z, Li E, Li X, Del Duke C, Shen H . Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs. Front Bioeng Biotechnol. 2020; 7:411. PMC: 6930794. DOI: 10.3389/fbioe.2019.00411. View

16.

Takayanagi H . Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007; 7(4):292-304. DOI: 10.1038/nri2062. View

17.

Zhang Z, Nagrath S . Microfluidics and cancer: are we there yet?. Biomed Microdevices. 2013; 15(4):595-609. PMC: 4017600. DOI: 10.1007/s10544-012-9734-8. View

18.

Picollet-Dhahan N, Zuchowska A, Lemeunier I, Le Gac S . Multiorgan-on-a-Chip: A Systemic Approach To Model and Decipher Inter-Organ Communication. Trends Biotechnol. 2021; 39(8):788-810. DOI: 10.1016/j.tibtech.2020.11.014. View

19.

Chen B, Sun L, Zhang X . Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J Autoimmun. 2017; 83:31-42. DOI: 10.1016/j.jaut.2017.03.009. View

20.

Lin H, Lozito T, Alexander P, Gottardi R, Tuan R . Stem cell-based microphysiological osteochondral system to model tissue response to interleukin-1β. Mol Pharm. 2014; 11(7):2203-12. PMC: 4086740. DOI: 10.1021/mp500136b. View